Scisparc Ltd (SPRC) - Total Liabilities

Latest as of March 2026: $2.48 Million USD

Based on the latest financial reports, Scisparc Ltd (SPRC) has total liabilities worth $2.48 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SPRC year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Scisparc Ltd - Total Liabilities Trend (2006–2025)

This chart illustrates how Scisparc Ltd's total liabilities have evolved over time, based on quarterly financial data.

Scisparc Ltd Competitors by Total Liabilities

The table below lists competitors of Scisparc Ltd ranked by their total liabilities.

Company Country Total Liabilities
Range International Ltd
AU:RAN
Australia AU$882.04K
Mercator Limited
NSE:MERCATOR
India Rs24.65 Billion
Seeing Machines Limited
LSE:SEE
UK GBX88.34 Million
Algorhythm Holdings, Inc.
NASDAQ:RIME
USA $10.74 Million
Magnetite Mines Ltd
AU:MGT
Australia AU$4.31 Million
Prestal Holdings Ltd
AU:PTL
Australia AU$4.34 Million
Infinity Mining Ltd
AU:IMI
Australia AU$392.72K
Kistos PLC
LSE:KIST
UK GBX901.48 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Scisparc Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Scisparc Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.41 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Scisparc Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Scisparc Ltd (2006–2025)

The table below shows the annual total liabilities of Scisparc Ltd from 2006 to 2025.

Year Total Liabilities Change
2025-12-31 $2.48 Million +75.78%
2024-12-31 $1.41 Million -11.72%
2023-12-31 $1.59 Million -61.62%
2022-12-31 $4.16 Million +134.14%
2021-12-31 $1.77 Million +56.94%
2020-12-31 $1.13 Million -0.79%
2019-12-31 $1.14 Million -74.57%
2018-12-31 $4.48 Million +280.88%
2017-12-31 $1.18 Million +75.14%
2016-12-31 $672.02K +31.56%
2015-12-31 $510.80K +35.31%
2014-12-31 $377.51K -45.74%
2013-12-31 $695.76K -0.99%
2012-12-31 $702.74K -52.58%
2011-12-31 $1.48 Million -69.67%
2010-12-31 $4.89 Million -25.73%
2009-12-31 $6.58 Million +163.36%
2008-12-31 $2.50 Million -56.97%
2007-12-31 $5.81 Million +37.15%
2006-12-31 $4.23 Million --

About Scisparc Ltd

NASDAQ:SPRC USA Biotechnology
Market Cap
$2.77 Million
Market Cap Rank
#29621 Global
#5971 in USA
Share Price
$4.84
Change (1 day)
+1.89%
52-Week Range
$0.50 - $11.54
All Time High
$200.20
About

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil… Read more